Form EFFECT Cadrenal Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 20, 2024 5:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- M&T Bank Strengthens Commitment to Connecticut with Expanded UConn Partnership and Gampel Pavilion Naming Rights
- Beyond Software: SuperQ Quantum Computing Advances a Full-Stack Vision for Quantum Supercomputing
- Building a Greener Circular Future: Fengcheng Conference Explores New Pathways for "Urban Mining"
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share